1. Encorafenib plus cetuximab treatment in BRAF V600E-mutated metastatic colorectal cancer patients pre-treated with an anti-EGFR: An AGEO-GONO case series. (June 2022) Authors: Hafliger, Emilie; Boccaccino, Alessandra; Lapeyre-Prost, Alexandra; Perret, Audrey; Gallois, Claire; Antista, Maria; Pilla, Lorenzo; Lecomte, Thierry; Scartozzi, Mario; Soularue, Emilie; Salvatore, Lisa; Bourgeois, Vincent; Salati, Massimiliano; Tougeron, David; Evesque, Ludovic; Vaillant, Jean-N... Journal: European journal of cancer Issue: Volume 168(2022) Page Start: 34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FOLFIRI plus BEvacizumab or aFLIbercept after FOLFOX‐bevacizumab failure for COlorectal cancer (BEFLICO): An AGEO multicenter study. Issue 11 (14th July 2022) Authors: Torregrosa, Cécile; Pernot, Simon; Vaflard, Pauline; Perret, Audrey; Tournigand, Christophe; Randrian, Violaine; Doat, Solene; Neuzillet, Cindy; Moulin, Valérie; Stouvenot, Morgane; Roth, Gael; Darbas, Tiffany; Auberger, Benjamin; Godet, Tiphaine; Jaffrelot, Marion; Lambert, Aurélien; Dubreuil, O... Journal: International journal of cancer Issue: Volume 151:Issue 11(2022) Page Start: 1978 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Gemcitabine plus nab-paclitaxel until progression or alternating with FOLFIRI.3, as first-line treatment for patients with metastatic pancreatic adenocarcinoma: The Federation Francophone de Cancérologie Digestive-PRODIGE 37 randomised phase II study (FIRGEMAX). (September 2020) Authors: Rinaldi, Yves; Pointet, Anne-Laure; Khemissa Akouz, Faiza; Le Malicot, Karine; Wahiba, Bidaut; Louafi, Samy; Gratet, Alain; Miglianico, Laurent; Laharie, Hortense; Bouhier Leporrier, Karine; Thirot Bidault, Anne; Texereau, Patrick; Coriat, Romain; Terrebonne, Eric; Gouttebel, Marie-Claude; Malka,... Journal: European journal of cancer Issue: Volume 136(2020) Page Start: 25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Modified FOLFIRINOX Versus CISGEM Chemotherapy for Patients With Advanced Biliary Tract Cancer (PRODIGE 38 AMEBICA): A Randomized Phase II Study. Issue 3 (20th January 2022) Authors: Phelip, Jean marc; Desrame, Jérôme; Edeline, Julien; Barbier, Emilie; Terrebonne, Eric; Michel, Pierre; Perrier, Hervé; Dahan, Laetitia; Bourgeois, Vincent; Akouz, Faiza Khemissa; Soularue, Emilie; Ly, Valérie Lebrun; Molin, Yann; Lecomte, Thierry; Ghiringhelli, François; Coriat, Romain; Louafi, ... Journal: Journal of clinical oncology Issue: Volume 40:Issue 3(2022) Page Start: 262 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Modified FOLFIRINOX versus CisGem first-line chemotherapy for locally advanced non resectable or metastatic biliary tract cancer (AMEBICA)-PRODIGE 38: Study protocol for a randomized controlled multicenter phase II/III study. Issue 2 (February 2019) Authors: Phelip, Jean-Marc; Edeline, Julien; Blanc, Jean-Frédéric; Barbier, Emilie; Michel, Pierre; Bourgeois, Vincent; Neuzillet, Cindy; Malka, David; Manfredi, Sylvain; Desrame, Jérôme Journal: Digestive and liver disease Issue: Volume 51:Issue 2(2019) Page Start: 318 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort. (July 2017) Authors: Stephanie, Laetitia; Borbath, Ivan; Castex, ; Petorin, Caroline; Terrebonne, Eric; Bouhier-Leporrier, Karine; Suc, Etienne; Hautefeuille, Vincent; Bourgeois, Vincent; Cany, Laurent; Dewaele, François; Niccoli, Patricia; Seitz, Jean-François; Lecaille, Cédric; Rebischung, Christine; Rossi, Valérie... Journal: European journal of cancer Issue: Volume 79(2017) Page Start: 158 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗